|
gptkbp:instance_of
|
gptkb:virus
|
|
gptkbp:belongs_to
|
gptkb:Herpesviridae
|
|
gptkbp:can_cause
|
congenital varicella syndrome
|
|
gptkbp:can_cause_severe_disease_in
|
newborns
|
|
gptkbp:can_detect
|
PCR testing
|
|
gptkbp:can_lead_to
|
secondary bacterial infections
|
|
gptkbp:can_reactivate_to_cause
|
shingles
|
|
gptkbp:can_remain_dormant_in
|
nerve cells
|
|
gptkbp:cause
|
chickenpox
shingles
viral meningitis
childhood rashes
hospitalization in children
|
|
gptkbp:communication_system
|
airborne droplets
direct contact with lesions
|
|
gptkbp:complications
|
gptkb:pneumonia
gptkb:multiple_sclerosis
|
|
gptkbp:diagnosis
|
clinical symptoms
|
|
gptkbp:difficulty_levels
|
immunocompromised individuals
|
|
gptkbp:discovered_by
|
gptkb:1954
|
|
gptkbp:has_a_focus_on
|
clinical research
public health campaigns
infectious disease research
|
|
gptkbp:has_a_vaccine
|
gptkb:Varicella_vaccine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Varicella-Zoster Virus
|
|
gptkbp:included
|
MMR-V vaccine
|
|
gptkbp:is_a_member_of
|
gptkb:alpha_herpesviruses
|
|
gptkbp:is_a_potential_cause_of
|
fetal varicella syndrome
|
|
gptkbp:is_a_subject_of
|
epidemiological studies
public health surveillance
vaccine safety studies
|
|
gptkbp:is_associated_with
|
postherpetic neuralgia
varicella pneumonia
chickenpox vaccine efficacy
|
|
gptkbp:is_contagious_for
|
1-2 days before rash appears
|
|
gptkbp:is_contagious_until
|
all lesions crusted over
|
|
gptkbp:is_involved_in
|
viral latency
|
|
gptkbp:is_known_to
|
reactivate after stress
|
|
gptkbp:is_linked_to
|
increased healthcare costs
increased risk of shingles
chickenpox complications
|
|
gptkbp:is_monitored_by
|
gptkb:CDC
|
|
gptkbp:is_often_seen_in
|
gptkb:children
|
|
gptkbp:is_part_of
|
herpesvirus family
human virome
|
|
gptkbp:is_related_to
|
gptkb:Epstein-Barr_virus
|
|
gptkbp:is_shed_from
|
skin lesions
|
|
gptkbp:is_studied_for
|
pathogenic mechanisms
|
|
gptkbp:is_studied_in
|
virology
|
|
gptkbp:issues
|
pregnant women
healthcare workers
immunocompromised patients
|
|
gptkbp:known_as
|
gptkb:VZV
|
|
gptkbp:prevention
|
vaccination
herd immunity
|
|
gptkbp:replaces
|
vesicular fluid
|
|
gptkbp:risk_factor
|
gptkb:herpes_zoster
stroke in older adults
|
|
gptkbp:scientific_classification
|
an enveloped virus
|
|
gptkbp:seed_dispersal
|
125 kb
|
|
gptkbp:targets
|
antiviral drug development
vaccine development
|
|
gptkbp:treatment
|
gptkb:acyclovir
antiviral medications
|
|
gptkbp:type_of
|
double-stranded DNA virus
|
|
gptkbp:bfsParent
|
gptkb:herpesviridae_family
|
|
gptkbp:bfsLayer
|
6
|